| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:26808063 | ||||
| pmid:25652019 | ||||
| pmid:24874467 | ||||
| pmid:21912810 | ||||
| pmid:1998734 | ||||
| pmid: | ||||
| Van Hoof F et al. | Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study. | 1985 | Biochem. J. | pmid:4038275 |
| Mentlein R et al. | Different induction of microsomal carboxylesterases, palmitoyl-CoA hydrolase and acyl-L-carnitine hydrolase in rat liver after treatment with clofibrate. | 1986 | Biochem. Pharmacol. | pmid:2874814 |
| Christensen E et al. | Beta-oxidation of medium chain (C8-C14) fatty acids studied in isolated liver cells. | 1989 | Biochim. Biophys. Acta | pmid:2752017 |
| Hagve TA and Christophersen BO | Evidence for peroxisomal retroconversion of adrenic acid (22:4(n-6)) and docosahexaenoic acids (22:6(n-3)) in isolated liver cells. | 1986 | Biochim. Biophys. Acta | pmid:2935195 |
| Christensen E et al. | Mitochondrial and peroxisomal oxidation of arachidonic and eicosapentaenoic acid studied in isolated liver cells. | 1986 | Biochim. Biophys. Acta | pmid:3022820 |
| Grønn M et al. | Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells. | 1991 | Biochim. Biophys. Acta | pmid:1825021 |
| Wernette-Hammond ME and Lardy HA | Regulation of gluconeogenesis in hepatocytes from fasted alloxan-diabetic rats. | 1985 | Diabetes | pmid:2991049 |
| Hayashi M and Tomita M | Mechanistic analysis for drug permeation through intestinal membrane. | 2007 | Drug Metab. Pharmacokinet. | pmid:17495413 |
| Christophersen BO and Norseth J | Arachidonic acid synthesis in isolated liver cells:" effects of (-)-carnitine and of (+)-decanoylcarnitine. | 1981 | FEBS Lett. | pmid:6796433 |
| Tonin AM et al. | Disruption of redox homeostasis in cerebral cortex of developing rats by acylcarnitines accumulating in medium-chain acyl-CoA dehydrogenase deficiency. | 2012 | Int. J. Dev. Neurosci. | pmid:22472139 |
| Tomita M et al. | Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. | 1996 | J Pharm Sci | pmid:8773957 |
| Chung CD and Bieber LL | Properties of the medium chain/long chain carnitine acyltransferase purified from rat liver microsomes. | 1993 | J. Biol. Chem. | pmid:8440734 |
| Tomita M et al. | Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. | 1995 | J. Pharmacol. Exp. Ther. | pmid:7853188 |
| Ziadeh R et al. | Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. | 1995 | Pediatr. Res. | pmid:7603790 |
Decanoylcarnitine
Decanoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
